Chemistry: molecular biology and microbiology – Process of mutation – cell fusion – or genetic modification – Mutation employing a chemical mutagenic agent
Reexamination Certificate
1999-04-29
2001-11-06
Stucker, Jeffrey (Department: 1648)
Chemistry: molecular biology and microbiology
Process of mutation, cell fusion, or genetic modification
Mutation employing a chemical mutagenic agent
C424S050000, C424S093440, C424S244100, C435S007340, C435S029000, C435S244000, C435S245000, C536S023100
Reexamination Certificate
active
06312955
ABSTRACT:
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to gram-positive bacterial strains resistant to 5-fluorodeoxyuridine, and to methods of producing such bacterial strains.
2. Description of the Related Art
Commensal Gram-positive bacteria are currently being developed as live vaccine vectors able to colonize mucosal surfaces and stimulate a secretory IgA, as well as a systemic immune, response to a recombinant antigen displayed on the surface of these organisms. One such promising live vaccine delivery system candidate is the oral bacterium
Streptococcus gordonii,
a component of human dental plaque which is able to colonize most oral sites. One important issue related to the utilization of these organisms as live vaccine vectors is the need to develop non-antibiotic selectable markers to employ during the manipulation of these recombinant organisms in the research and clinical laboratories, as well as to monitor colonization in animal studies and possible dispersal of these organisms in the environment.
Thymidine kinase (TK; EC 2.7.1.21) is a key enzyme in the salvage pathway of pyrimidine nucleotide metabolism which catalyzes the formation of thymidylate from thymidine and ATP. Previous studies in both
Escherichia coli
and
Salmonella typhimurium
have suggested it is possible to select for tdk mutations in essentially any genetic background on the basis of their resistance to the pyrimidine analog fluorodeoxyuridine. Presumably, when FUDR is phosphorylated by TK to 5-fluorodeoxyuridine monophosphate it inhibits thymidylate synthetase, the final enzyme in the de novo synthetic pathway to thymidylate synthesis. The resultant absence of a source of preformed thymidine will deplete the cell of the essential metabolite TMP and thus, the selection pressure for the mutation of tdk. Indeed, previous isolates of
Escherichia coli,
resistant to FUDR, all possessed mutations that mapped to a single locus at 27.5 minutes on the
E. coli
genetic map and were deficient in thymidine kinase activity. This suggests that the usual mechanism for FUdR-resistance is the loss of thymidine kinase activity and that all mutations in FUdR
r
mutants of
E. coli
occur at the tdk locus.
Since the gene encoding thymidine kinase of
S. gordonii
has been cloned and the nucleotide sequence determined, we sought to determine if the selection for FUdR-resistant strains of
S. gordonii
was possible and, if so, to evaluate it as a dominant selectable marker.
SUMMARY OF THE INVENTION
Briefly, the present invention features gram-positive bacteria resistant to 5-fluorodeoxyuridine (FUdR). Such bacteria will preferably be commensal, and will not be resistant to antibiotics. Bacteria according to the present invention may also be transformed with DNA encoding an antigenic protein. Such transformed bacteria may be used to formulate a vaccine, in order to stimulate an immune response to the antigenic protein in a patient.
The present invention further provides a method for isolating gram-positive bacteria resistant to FUdR.
With the foregoing and other objects, advantages and features of the invention that will become hereinafter apparent, the nature of the invention may be more clearly understood by reference to the following detailed description of the preferred embodiments of the invention and to the appended claims.
REFERENCES:
patent: WO9640943 (1996-12-01), None
Lehninger et al. Principals of Biochemistry. (1993) Worth Publishers Inc. pp. 715.*
Knox et al. Isoloation and characterization of mutants of mesophilic methonogenic bacteria resisitant to analogues of DNA bases and nucleosides. Archives of Microbiology. vol. 149 (1988) pp. 557-560.*
Franke et al, “Streptococcus gordoniiStrains Resistant to Fluorodeoxyuridine Contain Mutations in the Thymidine Kinase Gene and are Deficient in Thymidine Kinase Activity”,Antimicrobial Agents and Chemotherapy, vol. 44, No. 3, Mar. 2000, pp. 787-789 XP002154467.
Darland et al, “Isolation of a thymidine Kinase Negative Mutant of a Nocardia Lactamdurans”,Fems Microbiology Letters, vol. 65, pp. 229-232 (1989) XP000926057.
Mandelbaum-Shavit et al, “Mechanism of Resistance ofPediococcus CerevisiaeStrains to 5-Fluorodeoxyuridine”Biochimica et Biophysica Actavol. 543, pp. 1-9 (1978) XP000926054.
Bean et al, “5-Fluoropyrimidine-Resistant Mutants of Pneumococcus”Journal of Bacteriology, vol. 113, No. 3, pp. 1348-1355 (Mar. 1973) XP000926065.
Palu et al, “A Point Mutation in the Thymidine Kinase Gene is Responsible for Acyclovir-Resistance in Herpes Simplex Virus Type 2 Sequential Isolates”,Virus Research, vol. 25, pp. 133-144(1992) XP000926071.
Hruby, “Vaccinia Virus: A Novel Approach for Molecular Engineering of Peptide Vaccines”,Seminars in Hematology, vol. 30, No. 4, pp. 35-44 (Oct. 1993), XP000926093.
J. Martinussen et al, “Cloning and Characterization ofupp, a Gene Encoding Uracil Phosphoriboxyltransferase fromLactococcus Lactis” Journal of Bacteriology, Nov. 1994, p. 6457-6433, vol. 176, No. 21.
Beck et al., “Metabolism of Pyrimidines and Pyrimidine Nucleosides bySalmonella typhimurium”,Journal of Bacteriology, vol. 110, No. 1, pp. 219-228 (1972).
Black et al. “Nucleotide Sequence of theEscherichia coliThymidine Kinase Gene Provides Evidence for Conservation of Functional Domains and Quaternary Structure”,Molecular Microbiologyvol. 5, No. 2, pp. 373-379 (1991).
Drinkwater et al., “Chemically Induced Mutagenesis in a Shuttle Vector With a Low-background Mutant Frequency”,Proc. Natl. Acad. Sci.USA vol. 83, pp. 3402-3406 (1986).
Bollet et al., “A Simple Method for the Isolation of Chromosomal DNA from Gram Positive or Acid-fast Bacteria”Nucleic Acids Research, vol. 19, No. 8, p. 1955 (1991).
Black et al., “Site-directed Mutagenesis of a Conserved Domain in Vaccinia Virus Thymidine Kinase”Journal of Biological Chemistryvol. 267, No. 10, pp. 6801-6806 (1992).
Dube et al., “The Association of Thymidine Kinase Activity and Thymidine Transport inEscherichia coli”Genevol. 99, pp. 25-29 (1991).
Fischetti et al., “Expression of Foreign Proteins on Gram-Postive Commensal Bacteria for Musocal Vaccine Delivery”Curr. Opinions in Biotechnologyvol. 4, pp. 603-610 (1993).
Frandsen et al., “Ecology of Viridans Streptococci in the Oral Cavity and Pharynx”Oral Microbiol Immunol.vol. 6, pp. 129-133 (1991).
Hiraga et al., A Deoxythymidine Kinase-Deficient Mutant ofEscherichia Coli,Biochimica et Biophysica Actavol. 145 pp. 41-51 (1967).
Hruby et al., “Control of Expression of the Vaccinia Virus Thymidine Kinase Gene”, Journal of Virology, vol. 40, No. 2, pp. 456-464 (1981).
Hruby et al., “Mapping and Identification of the Vaccinia Virus Thymidine kinase Gene”,Journal of Virologyvol. 43, No. 2, pp. 403-409 (1982).
Igarashi et al., “A Deoxythymidine Kinase Deficient Mutant ofEscherichia ColiII. Mapping and Transduction Studies with Phage &PHgr;80”Geneticsvol. 57, pp. 643-654 (1967).
McNab, R., “Cloning and Sequence Analysis of Thymidine Kinase from the Oral BacteriumStreptoccus gordonii”FEMS Microbiology Lettersvol. 135, pp. 103-110 (1996).
Medaglini, D. et al. “Mucosal and Systemic Immune Responses to a Recombinant Protein Expressed on the Surface of the Oral Commensal BacteriumStreptococcus gordoniiAfter Oral Colonization”Proc. Natl. Acad. Sci. USAvol. 92, pp. 6868-6872 (1995).
Pozzi, G. et al. “Host-Vector System for Integration of Recombinant DNA into Chromosomes of Transformable and Nontransformable Streptococci”J Bacteriology, pp. 1969-1972 (1988).
Summers, W. C. et al. “A Method for Selection of Mutations at thetdkLocus inEscherichia coli”Journal of Bacteriologyvol. 175, No. 18 pp. 6049-6051 (1993).
Franke Christine A.
Hruby Dennis E.
Burns Doane Swecker & Mathis L.L.P.
Siga Pharmaceuticals
Stucker Jeffrey
Winkler Ulrike
LandOfFree
Streptococcus gordonii strains resistant to fluorodeoxyuridine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Streptococcus gordonii strains resistant to fluorodeoxyuridine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Streptococcus gordonii strains resistant to fluorodeoxyuridine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2582409